BIO’s partnering platform connects biotechnology companies, investors, and strategic partners, making the BIO International Convention one of the industry’s largest business development events. A […]
BIO 2026: The business of biotech runs on partnerships Read More »
BIO 2026 brings together 20,000 biotechnology leaders in San Diego for four days of partnering, policy discussions, AI, and innovation as the industry celebrates
BIO 2026 begins in San Diego, marking 50 years of biotech innovation Read More »
The last time the BIO International Convention was in San Diego, in 2024, Ram May-Ron of the non-dilutive funding specialists FreeMind Group began discussing
BIO 2026: Partnering meetings fill up for industry’s biggest gathering Read More »
Lawmakers defended strong IP protections as essential to biotech innovation that saves lives in a June 4 Congressional hearing that also considered the role
Lawmakers warn against weakening IP for medicines in House hearing Read More »
Researchers utilize health data to inform medical breakthroughs, but patients need to know their personal information stays confidential. The current patchwork of state laws
House hearing to examine bill balancing data privacy and R&D needs Read More »
The BIO International Convention, the world’s largest annual gathering of biotechnology stakeholders, provides an exceptional opportunity to make the connections that enable development of
Experts explain how to drive business development with BIO 2026 Read More »
Ohio’s diverse biotech sector provides the state with employment for 65,000 and provides the world with medical breakthroughs. Of the first eight gene therapies
BIO on the American Road tours gene therapy hub in Ohio Read More »
When a biotech firm sells investors on the promise of a new drug, what they are really selling is the intellectual property behind their
BIO is expanding its work to defend IP Read More »
As biotech celebrates its 50th year, we are locked in “the fight of our lives” to ensure patients get more of the medical innovations
Ensuring a brighter future for U.S. biotech requires modernizing the Food and Drug Administration (FDA) and addressing challenges from China, according to Kelly Seagraves,
BIO expert: Future of biotech depends on competing with China, updating FDA Read More »
